HomeCYP • ASX
add
Cynata Therapeutics Ltd
Previous close
$0.26
Day range
$0.26 - $0.26
Year range
$0.11 - $0.35
Market cap
45.81M AUD
Avg Volume
119.78K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
NVDA
4.76%
1.08%
Financials
Income Statement
Revenue
Net income
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 1.27M | 41.35% |
Operating expense | 3.54M | 1.62% |
Net income | -2.27M | 12.22% |
Net profit margin | -178.38 | 37.90% |
Earnings per share | — | — |
EBITDA | -2.20M | 12.56% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 11.17M | -31.96% |
Total assets | 13.45M | -34.45% |
Total liabilities | 1.18M | -20.05% |
Total equity | 12.27M | — |
Shares outstanding | 179.63M | — |
Price to book | 3.71 | — |
Return on assets | -42.20% | — |
Return on capital | -46.26% | — |
Cash Flow
Net change in cash
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -2.27M | 12.22% |
Cash from operations | -2.43M | 33.30% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -2.50M | 32.31% |
Free cash flow | -1.31M | 7.60% |
About
Founded
2003
Website